… as a follicular variant of papillary thyroid cancer, regardless of … trends of follicular variant of
papillary thyroid carcinoma at … rate trends of follicular thyroid cancer at regional stage in the …

… RET gene fusions are typical for papillary thyroid cancer. However, they could be rarely
detected in MTC. Only three reports showed the presence of fusion genes in sporadic MTC. …

… new molecular biomarkers are being evaluated. Here, we will review the current staging
systems of thyroid cancer … and new molecular markers that are potentially capable of refining the …

… from Follicular thyroid cells to papillary thyroid cancer (PTC) or follicular thyroid cancer (FTC) …
Molecular markers for diagnosis, prognosis, surveillance and treatment are becoming more …

… risk factors, and radiation. The prognosis of the patients with papillary thyroid carcinoma
is … of the clinical, pathological, and molecular parameters of papillary thyroid carcinoma. …

… papillary thyroid carcinoma (PTC) cases relapses, which directly impact on the quality of
patients' lives. The molecular … years) prognostic value of aggressiveness markers in advanced …

… survival rates, but prognosis highly depends on molecular and clinico-pathological
characteristics. For instance, the noninvasive follicular neoplasm with papillary-like nuclear features, …

… thyroid disease in adults have both comprehensively addressed the role of molecular testing
as a diagnostic and prognostic … of 105 patients with papillary thyroid cancer who were found …

… by papillary thyroid carcinoma, that arises from thyroid follicular … Several clinicopathological
prognostic factors for FTC have … Further studies using pathological and molecular aspects …

… Poor prognostic factors of PTC include older age at diagnosis, male gender, large tumour
size, and extrathyroidal growth 11 . An aggressive approach in the management and treatment …